E.A. Kiselev
Research Subjects
E.A. Kiselev has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- A. M. Shadiev
Sklifosovsky Research Institute for Emergency Care
2 shared publications - Mikhail Rogal
Sklifosovsky Research Institute for Emergency Care
2 shared publications - Peter A. Yartsev
N.V. Sklifosovsky Research Institute for Emergency Medicine; Russian Medical Academy of Continuous Professional Education
2 shared publications - Sergey V. Novikov
Sklifosovsky Research Institute for Emergency Care
2 shared publications - Yurii S. Teterin
Sklifosovsky Research Institute for Emergency Medicine
2 shared publications - Sergey S. Petrikov
N.V. Sklifosovsky Research Institute for Emergency Medicine
1 shared publication
Latest Publications
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7
Pancreatic duct stenting for prevention of acute post-manipulation pancreatitis in complicated cholelithiasis
Objective. To evaluate the effectiveness of pancreatic duct stenting for prevention of acute post-manipulation pancreatitis in complicated cholelithiasis. Material and methods. The study included emergency and urgent endoscopic transpapillary interventions in patients with cholelithiasis and no predictors of acute post-manipulation pancreatitis between January 2016 and May 2025. Patients were divided into two groups — with (main group) and without (comparison group) prophylactic pancreatic duct stenting. In both groups, mean age of patients, severity of mechanical jaundice, cholangitis, nature and number of surgical interventions were analyzed. We compared the incidence and severity of acute post-manipulation pancreatitis, necessary repeated endoscopic or surgical interventions, the number of patients requiring intensive care, ICU- and hospital-stay, as well as mortality. Results. When excluding patients with well-known predictors, no significant decrease in the incidence of acute post-manipulation pancreatitis was recorded (4.7% in the main group and 5.5% in the comparison group). In most cases, acute mild post-manipulation pancreatitis was detected (3.4% and 4.5%, respectively), and all symptoms regressed under therapy without repeated endoscopic intervention. In the main group, repeated endoscopic intervention was required in 3.4% of patients, in the comparison group — only 1%. This slightly prolonged duration of treatment (11.7 and 10.3 days, respectively). Conclusion. Routine retrograde pancreatic duct stenting for complicated cholelithiasis in middle-aged men without recognized predictors does not significantly reduce the incidence of acute post-manipulation pancreatitis.
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7
Pancreatic duct stenting for prevention of acute post-manipulation pancreatitis in complicated cholelithiasis
Objective. To evaluate the effectiveness of pancreatic duct stenting for prevention of acute post-manipulation pancreatitis in complicated cholelithiasis. Material and methods. The study included emergency and urgent endoscopic transpapillary interventions in patients with cholelithiasis and no predictors of acute post-manipulation pancreatitis between January 2016 and May 2025. Patients were divided into two groups — with (main group) and without (comparison group) prophylactic pancreatic duct stenting. In both groups, mean age of patients, severity of mechanical jaundice, cholangitis, nature and number of surgical interventions were analyzed. We compared the incidence and severity of acute post-manipulation pancreatitis, necessary repeated endoscopic or surgical interventions, the number of patients requiring intensive care, ICU- and hospital-stay, as well as mortality. Results. When excluding patients with well-known predictors, no significant decrease in the incidence of acute post-manipulation pancreatitis was recorded (4.7% in the main group and 5.5% in the comparison group). In most cases, acute mild post-manipulation pancreatitis was detected (3.4% and 4.5%, respectively), and all symptoms regressed under therapy without repeated endoscopic intervention. In the main group, repeated endoscopic intervention was required in 3.4% of patients, in the comparison group — only 1%. This slightly prolonged duration of treatment (11.7 and 10.3 days, respectively). Conclusion. Routine retrograde pancreatic duct stenting for complicated cholelithiasis in middle-aged men without recognized predictors does not significantly reduce the incidence of acute post-manipulation pancreatitis.
- 29 April 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 5,p. 5-12
Treatment of patients with obstructive jaundice in the flagship center
Objective. To improve treatment outcomes in patients with obstructive jaundice at the flagship center through distributing patient flows and applying optimal tactics. Material and methods. A retrospective study included patients with obstructive jaundice between January 2022 and April 2024. Patients were divided into 2 groups: the main group — patients hospitalized between March 2023 and April 2024 (the first year of work of the flagship center); the control group — patients hospitalized between January 2022 and February 2023 (one year before the commissioning of the flagship center). In both groups, we analyzed gender- and age-adjusted distribution of patients, channels of hospitalization, severity of obstructive jaundice and its etiology, nature and number of surgical interventions, postoperative morbidity and mortality. Mean time to diagnosis, waiting time for surgery, postoperative and overall hospital-stay were compared. Results. There was significantly lower postoperative morbidity in the main group (p<0.05). Moreover, the same group was characterized by significantly shorter time for diagnosis (3.4 versus 12.1 hours; p<0.0001), earlier surgical treatment (6.8 versus 17.4 hours; p<0.0001), postoperative (2.8 versus 5.7 days) and overall hospital-stay (3.6 versus 6.4 days). Conclusion. The capabilities of the flagship center make it possible to provide specialized high-tech medical care within the first hours after admission, significantly reduce the time for correct diagnosis and period until surgery. Original algorithm for patient distribution and optimal tactics based on minimally invasive technologies significantly improved treatment outcomes in patients with obstructive jaundice.
- 29 April 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 5,p. 5-12
Treatment of patients with obstructive jaundice in the flagship center
Objective. To improve treatment outcomes in patients with obstructive jaundice at the flagship center through distributing patient flows and applying optimal tactics. Material and methods. A retrospective study included patients with obstructive jaundice between January 2022 and April 2024. Patients were divided into 2 groups: the main group — patients hospitalized between March 2023 and April 2024 (the first year of work of the flagship center); the control group — patients hospitalized between January 2022 and February 2023 (one year before the commissioning of the flagship center). In both groups, we analyzed gender- and age-adjusted distribution of patients, channels of hospitalization, severity of obstructive jaundice and its etiology, nature and number of surgical interventions, postoperative morbidity and mortality. Mean time to diagnosis, waiting time for surgery, postoperative and overall hospital-stay were compared. Results. There was significantly lower postoperative morbidity in the main group (p<0.05). Moreover, the same group was characterized by significantly shorter time for diagnosis (3.4 versus 12.1 hours; p<0.0001), earlier surgical treatment (6.8 versus 17.4 hours; p<0.0001), postoperative (2.8 versus 5.7 days) and overall hospital-stay (3.6 versus 6.4 days). Conclusion. The capabilities of the flagship center make it possible to provide specialized high-tech medical care within the first hours after admission, significantly reduce the time for correct diagnosis and period until surgery. Original algorithm for patient distribution and optimal tactics based on minimally invasive technologies significantly improved treatment outcomes in patients with obstructive jaundice.